List of Contract Manufacturing Companies in Italy - 10

Anemocyte is an Italian Biotech Manufacturing Organization with a strong focus on the development, manufacturing, and analytical services to address needs in the field of: • pDNA – Plasmids manufacturing (R&D, Hiqh-Quality, and GMP) for Viral Vector and mRNA; • mRNA – mRNA manufacturing (R&D) for vaccines and therapeutic treatments. Our experience: • More than 20 years of development and manufacturing experience (from R&D to GMP) in the field of Cell and Gene Therapies and Nucleic Acids. • Over the years, Anemocyte has been involved in multiple projects with a wide range of complexity.

At Angelini Pharma, we work every day to grow as a leading Pharma Company that makes a difference in patients' life. Since 1919. We aim at becoming a leading European player, offering people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life. We make our vision real through robust pipeline growth, strong collaborations with best-in-class Research Institutes and valuable partnerships with our strategic allies. We pledge to successfully develop distinctive treatments for CNS and Mental Health disorders while preserving our leading position in the Consumer Health segment. Angelini Pharma is part of Angelini Industries. Social media privacy notice: https://bit.ly/socialmediaprivacynotice

Comecer, an ATS company, develops and manufactures high-tech systems for Aseptic Processing and Containment in Pharmaceutical and Nuclear Medicine Industries, specialising in isolation technology solutions for regenerative medicine and tissue engineering. We develop highly innovative technologies and sustainable solutions, according to the latest GMP (Good Manufacturing Practice) regulations. The ability to build tailor-made solutions for our clients has been vital to our success. We operate in industries where each client has unique requirements, so standard solutions in most cases are not a good fit. That's why we always start new projects by listening to client needs and requirements. We assign a dedicated project team that analyses and understands the processes and the environment since no two organizations have identical characteristics. This team collects all the data, studies all aspects and designs solutions. This is where years of experience come into play. We then discuss with the client the possible alternatives that can meet their requirements. Many customers are not aware of how much customization is possible and our proposals surprise them. Containment: isolators to handle highly active principles or excipients (ATEX, where required), isolators to load reactors, multi-stage isolators for chemical synthesis or laboratory operations. Asepsis: isolators for sterility tests and formulation of sterile drugs, isolators/RABs integrated into the liquid or powder filling lines, dedicated solutions for Regenerative Medicine applications. Grade A pharmaceutical continuity: RABs, laminar flow trolleys, transfer hatch (with VPHP, where required). We also operate in the field of nuclear medicine and radiochemistry with the production of shielding systems and equipment for unique applications, for large industrial groups and research organisations, ensuring minimal exposure for the operator, total decontamination and inalterability under any working conditions.

Founded in 2002 in Cartoceto (PU), Italy, Diatheva is a biotechnology company established as a spin-off from the University of Urbino. 70% of all employees holds at least a PhD and oversees all phases of activity, from research and development to production and finishing. For 20 years, Diatheva has been engaged in the research, development, and production of: - biotechnological products: including monoclonal and polyclonal antibodies, antibody fragments, recombinant proteins, recombinant enzymes, and antigens - molecular and immunoenzymatic assays: such as in vitro diagnostics (IVD), veterinary kits, food analysis kits, and environmental kits. To achieve this, Diatheva collaborates with companies, public and private entities, mainly operating in the fields of oncology, microbial infections, and pharmacogenetics. Diatheva operates a cutting-edge GMP production facility authorized by AIFA since 2006 for biomolecules (APIs) and since 2023 for medicinal products.

Dompé farmaceutici is an international biopharmaceutical company involved in all activities of the pharmaceutical value chain, from research to development, production and marketing. As a long-established family company, we blend the stability that comes from our 130-year heritage with the agility and dynamism of a start-up. We can turn transformative breakthroughs into treatments because we have the right qualities and capabilities to deliver new drugs. Our 160,000 square meter R&D and production site in L’Aquila, Italy, is the heart of Dompé. Here, we conduct vital research, and produce and distribute our primary care and biotech products. Primary Care includes a broad spectrum of over-the-counter treatment solutions, prescription medications, supplements and medical devices. Our Biotech focuses on the development of treatments for rare diseases. The main therapeutic areas include pain relief, inflammation, ophthalmology, diabetes care, nutrition and oncology. In the pursuit of improving human health, our R&D strives to break through in unconventional places. This is what led us to Nerve Growth Factor (NGF), a Nobel Prize-winning discovery made in 1986. We leveraged 50 years of research to transform this discovery into a breakthrough treatment. Our human recombinant NGF, cenegermin, is the first treatment for a rare degenerative eye disease, neurotrophic keratitis. That deep appreciation of science keeps us committed to investigating neurotrophins. Our relentless pursuit in identifying new treatments for diseases allowed us to harness the potential of bioinformatics to accelerate the drug discovery process. The result is Exscalate, a structure-based virtual screening platform developed in-house and currently one of the most powerful supercomputing and artificial intelligence platforms for drug testing. We are focused on the road ahead. Our hunger to deliver what patients need from science keeps us focused on what matters. We embrace the challenge in science.

Since 1998 LABOMAR and LABOMAR RESEARCH add innovation and technological excellence to your products. LABOMAR is particularly skilled in the manufacturing of Food Supplements, Medical Devices, Foods for Special Medical Purposes, Functional Foods and Cosmetics, most of them derived from internal development and based on innovative patented technologies. Labomar products are a guarantee of safety for Customers and End-users, in compliance with the principles of Good Manufacturing Practice and Quality. In this perspective, Labomar obtained three prestigious certifications: UNI EN ISO 9001:2008, CEI UNI EN ISO 13485:2012 and GMP (Code of Federal Regulation, Title 21, Volume 2, part 111). Visit our website www.labomar.com

Olon is a global leader in the development and production of active pharmaceutical ingredients (APIs) for CDMO and Generics. We supply more than 300 Active Pharmaceutical Ingredients globally, with one of the most extensive track records in the industry. We provide an integrated package of chemical synthesis and biological processing services which clients can use to manage their drug manufacturing projects fully compliant with regulations. We rely on the broadest technical expertise while maintaining a long-standing quality and reliability Thanks to 2.300 employees and 300 highly experienced and qualified people in R&D team, we are a highly reliable partner. Our global manufacturing networks implies 11 manufacturing sites and 7 R&D departments across the globe, on several decades of experience in supporting pharmaceutical, biotech, food, chemical and bio-industrial companies.

ReiThera is a company devoted to developing and producing biopharmaceutical products based on gene delivery technologies doe advanced therapies, in order to prevent and treat several serious or life-threatening diseases.

We make the injection of medicines safer - keeping people safe from infections! Roncadelle Operations is committed to increasing the safety of drug injections and improving the protection of patients and healthcare workers. We are dedicated to reducing the spread of infectious diseases and promoting safer healthcare. Our product portfolio includes a range of patented safety syringes and needle protection systems for pre-filled syringes and cartridges. They are easy to use, offer good value for money and meet current and increasingly stringent regulatory and legal requirements. As a drug delivery device and packaging specialist, we offer value-added services from design to commercialization with scale-up manufacturing solutions. Our services range from customized user-centered design and prototyping to high-quality end-to-end manufacturing solutions. This reflects our commitment to excellence in the healthcare and pharma industry. From the heart of Europe, Roncadelle Operations offers design expertise and state-of-the-art cleanroom production capabilities in proximity to our clients in the pharmaceutical and healthcare industries. We are happy to service your needs! Let's talk.

Founded in 1949, Stevanato Group is one of the world's largest providers of integrated containment and delivery solutions for the biopharmaceutical industry. From the beginning, the Group has developed its own glass forming technology to ensure quality of the highest standards. The Group includes a wide range of skills dedicated to serving the biopharmaceutical and diagnostic industry. It offers glass containers with its historic Ompi brand, plastic components for diagnostics and medical devices, contract manufacturing services for drug delivery systems, up to inspection, assembly and packaging machines. The Group also provides analytical services and tests that study the interaction between container and drug and integration into delivery sys-tems, supporting the drug development process. By bringing together several skills under the same entity, Stevanato Group is able to offer unique solutions to companies by reducing the time to market and the overall cost.